{
  "cik": 1563880,
  "cik_padded": "0001563880",
  "entityName": "Trevi Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-110783",
      "filed": "2026-03-17",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12000.0,
        "cash": 18914000.0,
        "eps_diluted": -0.32,
        "free_cash_flow": -42101000.0,
        "net_income": -42759000.0,
        "operating_cash_flow": -42089000.0,
        "operating_income": -49328000.0,
        "stockholders_equity": 183244000.0,
        "total_assets": 193439000.0,
        "total_liabilities": 10195000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05563620091244461,
        "roa_avg2y": -0.2809958631657461,
        "roa_period_end": -0.22104642807293257,
        "roe_avg2y": -0.30230338508526344,
        "roe_period_end": -0.23334461155617647
      }
    },
    {
      "accn": "0001193125-26-110783",
      "filed": "2026-03-17",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 35000.0,
        "cash": 34097000.0,
        "eps_diluted": -0.47,
        "free_cash_flow": -38291000.0,
        "net_income": -47911000.0,
        "operating_cash_flow": -38256000.0,
        "operating_income": -51524000.0,
        "stockholders_equity": 99644000.0,
        "total_assets": 110900000.0,
        "total_liabilities": 11256000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.11296214523704387,
        "roa_avg2y": -0.47838524635177704,
        "roa_period_end": -0.43201983769161406,
        "roe_avg2y": -0.5259425547914003,
        "roe_period_end": -0.48082172534221823
      }
    },
    {
      "accn": "0001193125-26-110783",
      "filed": "2026-03-17",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 137000.0,
        "cash": 32397000.0,
        "eps_diluted": -0.29,
        "free_cash_flow": -31847000.0,
        "net_income": -29065000.0,
        "operating_cash_flow": -31710000.0,
        "operating_income": -33923000.0,
        "stockholders_equity": 82547000.0,
        "total_assets": 89403000.0,
        "total_liabilities": 6856000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08305571371461107,
        "roa_avg2y": -0.2736585411782429,
        "roa_period_end": -0.32510094739550127,
        "roe_avg2y": -0.305937707230298,
        "roe_period_end": -0.3521024386107309
      }
    },
    {
      "accn": "0000950170-25-041194",
      "filed": "2025-03-18",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 159000.0,
        "cash": 12589000.0,
        "eps_diluted": -0.45,
        "free_cash_flow": -28334000.0,
        "net_income": -29152000.0,
        "operating_cash_flow": -28175000.0,
        "operating_income": -29907000.0,
        "stockholders_equity": 107459000.0,
        "total_assets": 123015000.0,
        "total_liabilities": 15556000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14476218836951768,
        "roa_avg2y": -0.3610378351600718,
        "roa_period_end": -0.23697923017518188,
        "roe_avg2y": -0.46817736521753095,
        "roe_period_end": -0.27128486213346487
      }
    },
    {
      "accn": "0000950170-24-034167",
      "filed": "2024-03-20",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 36830000.0,
        "eps_diluted": -1.49,
        "net_income": -33940000.0,
        "operating_cash_flow": -28946000.0,
        "operating_income": -32476000.0,
        "stockholders_equity": 17075000.0,
        "total_assets": 38475000.0,
        "total_liabilities": 21400000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.253294289897511,
        "roa_avg2y": -0.7929350746443007,
        "roa_period_end": -0.8821312540610786,
        "roe_avg2y": -1.5303108866695223,
        "roe_period_end": -1.987701317715959
      }
    },
    {
      "accn": "0001564590-22-010875",
      "filed": "2023-03-16",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 32000.0,
        "cash": 45001000.0,
        "free_cash_flow": -29032000.0,
        "net_income": -32758000.0,
        "operating_cash_flow": -29000000.0,
        "operating_income": -32489000.0,
        "stockholders_equity": 27282000.0,
        "total_assets": 47131000.0,
        "total_liabilities": 19849000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7275492999046991,
        "roa_avg2y": -0.6115446365231677,
        "roa_period_end": -0.6950414801298508,
        "roe_avg2y": -0.8006648172363645,
        "roe_period_end": -1.2007184224030496
      }
    },
    {
      "accn": "0001564590-22-010875",
      "filed": "2022-03-17",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 9000.0,
        "cash": 57313000.0,
        "free_cash_flow": -23102000.0,
        "net_income": -26050000.0,
        "operating_cash_flow": -23093000.0,
        "operating_income": -26645000.0,
        "stockholders_equity": 54545000.0,
        "total_assets": 60001000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.7387241765564961,
        "roa_period_end": -0.4341594306761554,
        "roe_avg2y": 0.9481519226919507,
        "roe_period_end": -0.4775873132276102
      }
    },
    {
      "accn": "0001564590-21-015506",
      "filed": "2021-03-25",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 158000.0,
        "cash": 7202000.0,
        "free_cash_flow": -18447000.0,
        "net_income": -20545000.0,
        "operating_cash_flow": -18289000.0,
        "operating_income": -18408000.0,
        "stockholders_equity": -109494000.0,
        "total_assets": 10526000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -1.9518335550066501,
        "roe_avg2y": 0.2118893163230577
      }
    },
    {
      "accn": "0001564590-20-010996",
      "filed": "2020-03-16",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -84428000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-110783",
    "filed": "2026-03-17",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001563880.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001563880.json"
  },
  "ticker": "TRVI"
}